Publications by authors named "Max Hoermann"

Claim this Profile
T
Tissue-Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging Concepts.
Peter Valent, Johann Wojta, Petri T Kovanen, Olivier Hermine, Falko Fend, Gregor Hoermann

Am J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal haematopoiesis of indeterminate potential and mortality in coronary artery disease.
Moritz von Scheidt, Shaunak S Adkar, Johannes Krefting, Gregor Hoermann, Manja Meggendorfer

Eur Heart J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of blast counts for genetic subclassification in MDS.
Sandra Huber, Torsten Haferlach, Stephan Hutter, Gregor Hoermann, Wolfgang Kern

Leukemia· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic landscape of CCUS compared to MDS and its implications on risk prediction.
Sandra Huber, Constance Baer, Stephan Hutter, Natalie Wossidlo, Gregor Hoermann

Leukemia· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients.
Sandra Huber, Natalie Wossidlo, Torsten Haferlach, Stephan Hutter, Wencke Walter, Gregor Hoermann

Leukemia· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022.
Francis Baumgartner, Constance Baer, Stefanos Bamopoulos, Edward Ayoub, Marietta Truger, Gregor Hoermann

Blood· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy.
Daria Frank, Pradeep Kumar Patnana, Jan Vorwerk, Lianghao Mao, Lavanya Mokada Gopal, Gregor Hoermann

Blood· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC.
Sandra Huber, Constance Baer, Stephan Hutter, Frank Dicker, Irene Fuhrmann, Gregor Hoermann

Leukemia· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AML classification in the year 2023: How to avoid a Babylonian confusion of languages.
Sandra Huber, Constance Baer, Stephan Hutter, Frank Dicker, Manja Meggendorfer, Gregor Hoermann

Leukemia· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk prediction in MDS: independent validation of the IPSS-M-ready for routine?
Constance Baer, Sandra Huber, Stephan Hutter, Manja Meggendorfer, Niroshan Nadarajah, Gregor Hoermann

Leukemia· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDS subclassification-do we still have to count blasts?
Sandra Huber, Torsten Haferlach, Heiko Müller, Manja Meggendorfer, Stephan Hutter, Gregor Hoermann

Leukemia· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts.
Sandra Huber, Torsten Haferlach, Manja Meggendorfer, Stephan Hutter, Gregor Hoermann

Leukemia· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosis.
Sandra Huber, Torsten Haferlach, Manja Meggendorfer, Stephan Hutter, Gregor Hoermann

Leukemia· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SF3B1 mutations in AML are strongly associated with MECOM rearrangements and may be indicative of an MDS pre-phase.
Sandra Huber, Torsten Haferlach, Manja Meggendorfer, Stephan Hutter, Gregor Hoermann

Leukemia· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genome-wide association study identifies key modulators of complement factor H binding to malondialdehyde-epitopes.
Lejla Alic, Nikolina Papac-Milicevic, Darina Czamara, Ramona B Rudnick, Maria Ozsvar-Kozma, Gregor Hoermann

Proc Natl Acad Sci U S A· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL.
Christian Schmidl, Gregory I Vladimer, André F Rendeiro, Susanne Schnabl, Thomas Krausgruber, Gregor Hoermann

Nat Chem Biol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy.
Edit Porpaczy, Sabrina Tripolt, Andrea Hoelbl-Kovacic, Bettina Gisslinger, Zsuzsanna Bago-Horvath, Gregor Hoermann

Blood· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis